CompletedNot Applicable

Universal Screening Program for Cytomegalovirus Infection in the First Trimester of Pregnancy (CITEMB Study)

Spain3,357 participantsStarted 2022-04-21

Plain-language summary

The aim of this study is to evaluate a universal cCMV screening programme in the first trimester of pregnancy in primary care in Catalonia (Spain).

Who can participate

Age range16 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * maternal age 16 years or older, and * gestational age less than 14 weeks. Exclusion Criteria: * language barrier preventing informed consent, * gestational age at blood sampling above 14 weeks, and * consent withdrawal

What they're measuring

CMV seroprevalence in first trimester of pregnancy

Timeframe: 18-19 months

Prevalence of CMV primary infection in the first trimester of pregnancy or in the periconceptional period

Timeframe: 18-19 months

Fetal infection rate at 2nd trimester amniocentesis

Timeframe: 3-24 months

Rate of fetal compromise by imaging techniques (ultrasound and MRI) after first trimester / periconceptional CMV infection

Timeframe: 3-24 months

Neonatal infection rate (congenital CMV)

Timeframe: 6-27 months

Trial details

NCT IDNCT05699421

SponsorFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Screening trials